Xiaohong Xu

机构：Nantong Tumor Hospital, First Affiliated Hospital of Jinan University, Tianjin Medical University, Nanjing Medical University · ORCID：0009-0007-2576-3441

发表论文 168 篇 · 总被引 4377 次 · h-index 33

代表论文

• Metformin inhibits ovarian granular cell pyroptosis through the miR-670-3p/NOX2/ROS pathway (2023 · Aging · 被引 45)
• Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity (2023 · Journal of Experimental & Clinical Cancer Research · 被引 30)
• CHCHD2 up-regulation in Huntington disease mediates a compensatory protective response against oxidative stress (2024 · Cell Death and Disease · 被引 29)
• Neuroprotective role of CHCHD2 in Parkinson's disease: Insights into the GPX4-related ferroptosis pathway (2024 · Free Radical Biology and Medicine · 被引 13)
• An environmental-friendly resistance inducer in crop protection: V2C MXene nanosheets induce plant resistance to Ralstonia solanacearum via the ET/JA signaling pathway (2024 · Industrial Crops and Products · 被引 10)
• Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis (2023 · Journal of Orthopaedic Surgery and Research · 被引 6)